Factors Influencing Adherence Behavior for Daily and Intermittent Regimens of Pre-Exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) in Kenya. In Adherence 2013. presented at the 02/06/2013, Miami, FL. Retrieved from http://www.iapac.org/AdherenceConference/Adherence_2013.html. (2013).
Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial. PLoS One, 8, e74314. presented at the 09/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24086333. (2013).
Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials. PLoS ONE, 3, e2043. presented at the 04/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18446196. (2008).
A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials. In AIDS Vaccine 2008 Conference. presented at the 13/10/2008, Cape Town, South Africa. Retrieved from http://www.vaccineenterprise.org/conference_archive/2008/index.html. (2008).